Market Value4,844,538,000
Total Holdings69
File Date2016-08-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BAC / Bank of America Corporation Call
AGIO / Agios Pharmaceuticals, Inc.
HZNP / Horizon Therapeutics Plc
SRPT / Sarepta Therapeutics, Inc. Call
LCTX / Lineage Cell Therapeutics, Inc.
MET / MetLife, Inc.
MET / MetLife, Inc. Call
/ Weight Watchers International, Inc.
NKTR / Nektar Therapeutics
IONS / Ionis Pharmaceuticals, Inc.
INCY / Incyte Corporation
CLCD / CoLucid Pharmaceuticals, Inc.
GBT / Global Blood Therapeutics Inc.
IBM / International Business Machines Corporation Call
GLPI / Gaming and Leisure Properties, Inc.
LC / LendingClub Corporation
PARN / Parnell Pharmaceuticals Holdings Ltd.
SPNC / Spectranetics Corp. (The)
JUNO / Juno Therapeutics, Inc. Call
ONCE / Spark Therapeutics, Inc.
OCX / OncoCyte Corporation
JD / JD.com, Inc. - Depositary Receipt (Common Stock) Call
USFD / US Foods Holding Corp.
JUNO / Juno Therapeutics, Inc.
CELG / Celgene Corp.
AVXS / AveXis, Inc.
MLNT / Melinta Therapeutics, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
DMTX / Dimension Therapeutics, Inc.
KITE / Kite Pharma, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
/ Ceres, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Call
BLUE / bluebird bio, Inc.
BLUE / bluebird bio, Inc. Call
CELG / Celgene Corp. Call
451731103 / Ignyta, Inc.
RDUS / Radius Recycling, Inc. Call
RDUS / Radius Recycling, Inc.
CCXI / ChemoCentryx Inc
BABA / Alibaba Group Holding Limited - Depositary Receipt (Common Stock)
MA / Mastercard Incorporated
AGIO / Agios Pharmaceuticals, Inc. Call
GS / The Goldman Sachs Group, Inc.
GS / The Goldman Sachs Group, Inc. Call
IBRX / ImmunityBio, Inc.
C / Citigroup Inc. Call
MCRB / Seres Therapeutics, Inc.
XLRN / Acceleron Pharma Inc
BIIB / Biogen Inc. Call
C / Citigroup Inc.
REGN / Regeneron Pharmaceuticals, Inc.
REGN / Regeneron Pharmaceuticals, Inc. Call
JPM / JPMorgan Chase & Co. Call
JPM / JPMorgan Chase & Co.
WMT / Walmart Inc. Call
MS / Morgan Stanley
CLDX / Celldex Therapeutics, Inc.
DAL / Delta Air Lines, Inc.
AAPL / Apple Inc. Call
/ Array BioPharma, Inc.
VRTX / Vertex Pharmaceuticals Incorporated Call
BUFF / Innovator ETFs Trust - Innovator Laddered Allocation Power Buffer ETF
AGEN / Agenus Inc.
RGNX / REGENXBIO Inc.
RARE / Ultragenyx Pharmaceutical Inc.
ISEE / IVERIC bio Inc
BMRN / BioMarin Pharmaceutical Inc.
NTLA / Intellia Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc. Call
NBIX / Neurocrine Biosciences, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
/ Truist Financial Corporation Depositary Shares, each representing a 1/1,000th interest in a share of
BAC / Bank of America Corporation
ALNY / Alnylam Pharmaceuticals, Inc. Call
GOOGL / Alphabet Inc. Call
PANW / Palo Alto Networks, Inc.
FOLD / Amicus Therapeutics, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
AGEN / Agenus Inc. Call
TSLA / Tesla, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.